FIELD: medicine.
SUBSTANCE: present invention relates to a compound of the formula
,
where R1 is H; R2 and R3 are OH; R4 is O-C1-6alkyl; R5 is NH, and R6 is 2-pyrrolino-daunozamine or 2-pyrrolino-epidaunozamine, which is used for suppression of fibrosarcoma cell growth. The invention also relates to a pharmaceutical composition and to a synergetic combined preparation containing this compound, as well as to a method for suppression of fibrosarcoma cell growth.
EFFECT: provision of an anthracycline compound containing 2-pyrrolino-group, which increases anticancer activity, while saving a good safety profile.
20 cl, 4 tbl, 4 ex
Title |
Year |
Author |
Number |
CANCER THERAPY BY COMBINATION OF TAXANES AND 13-DEOXYANTRACYCLINES |
2007 |
- Olson Richard D.
- Uolsh Dzheral'D M.
|
RU2421224C2 |
ANTHRACYCLINE GLYCOSIDE AND METHOD OF ITS SYNTHESIS |
1992 |
- Antonio Suarato[It]
- Franchesko Andzheluchchi[It]
- Al'Berto Bardzhotti[It]
- Marija Grandi[It]
- Gabriehlla Petstsoni[It]
|
RU2081878C1 |
DERIVATIVES OF 3'-AZIRIDINO-ANTHRACYCLINE, METHODS OF SYNTHESIS, PHARMACEUTICAL COMPOSITION |
1994 |
- Bardzhotti Al'Berto
- Karuzo Mikele
- Grandi Marija
- Ripamonti Marina
- Suarato Antonio
|
RU2149163C1 |
DERIVATIVES OF 5-IMINO-13-DEOXYANTHRACYCLINE AND METHOD FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT OF CANCER, AUTOIMMUNE DISEASES OR IMMUNODEFICIENT DISORDERS |
1999 |
- Zkhang Khini
- Olson Richard D.
|
RU2239640C2 |
BINDING AGENT FOR BIOACTIVE PREPARATIONS, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS |
1991 |
- Franchesko Andzheluchchi
- Laura Bersani
- Mikele Karuzo
- Marina Ripamonti
- Daniehla Rudzheri
- Antonino Suarato
|
RU2116087C1 |
ANTHRACYCLINE GLYCOSIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS SHOWING ANTITUMOR PROPERTIES, AND A METHOD OF THEIR SYNTHESIS |
1990 |
- Antonino Suarato[It]
- Franchesko Andzheluchchi[It]
- Al'Berto Bardzhotti[It]
- Marija Grandi[It]
- Gabriehlla Petstsoni[It]
|
RU2043360C1 |
COMBINED THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR CANCER TREATMENT |
2016 |
|
RU2752506C2 |
COMBINATION THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR TREATMENT OF CANCER |
2016 |
|
RU2786570C2 |
CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE IN TREATING CANCER-RELATED FATIGUE |
2021 |
- Allegretti, Marcello
- Ruffini, Pieradelchi
|
RU2832833C1 |
COMBINATIONS (COMPOSITIONS), INCLUDING DMXAA FOR CANCER TREATMENT |
2006 |
- Grin Kolin
- Kelland Llojd
- Roulinson-Basza Gejl
|
RU2404765C2 |